Dec 17 (Reuters) - Janssen Inc:
* HEALTH CANADA APPROVES DARZALEX® (DARATUMUMAB) FOR NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA WHO ARE TRANSPLANT INELIGIBLE
* JANSSEN - HEALTH CANADA APPROVAL OF DARZALEX FOR NEWLY DIAGNOSED PATIENTS WITH MULTIPLE MYELOMA WHO ARE TRANSPLANT INELIGIBLE MARKS ITS THIRD INDICATION